//--> //--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Retain my current filters
~isPartOf:"The European journal of health economics : HEPAC ; health economics in prevention and care"
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Search: subject_exact:"Pharmaceuticals"
Narrow search
Delete all filters
| 1 applied filter
Year of publication
From:
To:
Subject
All
Arzneimittel
111
Pharmaceuticals
111
Gesundheitskosten
34
Health care costs
34
Pharmaceutical industry
31
Pharmaindustrie
31
Arzneimittelmarkt
26
Pharmaceutical market
26
Gesundheitswesen
17
Health care system
17
Deutschland
16
Germany
16
Gesundheitsökonomik
15
Health economics
15
Gesundheitspolitik
11
Gesundheitsversorgung
11
Health care
11
Health policy
11
Impfung
11
Vaccination
11
Preisregulierung
10
Price regulation
10
Cost-effectiveness analysis
9
Drogenkonsum
9
Drug consumption
9
Innovation
9
Kosten-Wirksamkeits-Analyse
9
Price
9
Pharmacology
8
Pharmakologie
8
Preis
8
EU countries
7
EU-Staaten
7
Infectious disease
7
Infektionskrankheit
7
Regulation
7
Regulierung
7
Theorie
7
Theory
7
Cost-benefit analysis
6
more ...
less ...
Online availability
All
Undetermined
48
Type of publication
All
Article
111
Type of publication (narrower categories)
All
Article in journal
111
Aufsatz in Zeitschrift
111
Market information
1
Marktinformation
1
Language
All
English
111
Author
All
Garattini, Livio
6
Schulenburg, Johann-Matthias von der
6
Drummond, Michael F.
4
Gandjour, Afschin
4
Péntek, Márta
4
Stargardt, Tom
4
Antoñanzas Villar, Fernando
3
Baji, Petra
3
Gulácsi, László
3
Jönsson, Bengt
3
Kanavos, Panos
3
Kuhlmann, Alexander
3
Padula, Anna
3
Towse, Adrian
3
Van de Vooren, Katelijne
3
Anell, Anders
2
Blankart, Katharina
2
Brodszky, Valentin
2
Curto, Alessandro
2
Dalen, Dag Morten
2
Damm, Oliver
2
Dintsios, Charalabos-Markos
2
Fontrier, Anna-Maria
2
Gill, Jennifer
2
Lichtenberg, Frank R.
2
Lindgren, Peter
2
Rodríguez-Ibeas, Roberto
2
Rovira Forns, Joan
2
Rutten, F. F. H.
2
Ahumada-Canale, Antonio
1
Al-Janabi, Hareth
1
Andrade, Luiz Flavio
1
Angelis, Aris
1
Armeni, Patrizio
1
Augustin, Matthias
1
Baars, Erik W.
1
Balg, C.
1
Balogh, Orsolya
1
Banerjee, Tannista
1
Barbieri, Marco
1
more ...
less ...
Published in...
All
The European journal of health economics : HEPAC ; health economics in prevention and care
NBER working paper series
337
NBER Working Paper
263
Working paper / National Bureau of Economic Research, Inc.
260
Journal of health economics
119
Health economics
109
International journal of pharmaceutical and healthcare marketing : IJPHM
79
Discussion paper series / IZA
64
Health affairs : at the intersection of health, health care, and policy
63
CESifo working papers
57
Research paper
54
Health marketing quarterly
51
Journal of medical marketing : device, diagnostic and pharmaceutical marketing
46
Discussion papers / CEPR
36
Health economics review
33
Working paper
31
Management science : journal of the Institute for Operations Research and the Management Sciences
30
Applied economics
29
IZA Discussion Paper
29
Journal of pharmaceutical finance, economics & policy
28
Research policy : policy, management and economic studies of science, technology and innovation
28
The European journal of health economics
28
International journal of the economics of business
27
International journal of health economics and management
26
CESifo Working Paper Series
25
CESifo Working Paper
24
Journal of illicit economies and development : JIED
24
Journal of research in pharmaceutical economics
23
Applied economics letters
22
Economics letters
22
International journal of industrial organization
22
The American economic review
22
European journal of operational research : EJOR
21
Research papers / South Centre
21
Working Papers / eSocialSciences
21
American economic journal : a journal of the American Economic Association
20
Forum for health economics & policy : an evolving collection of symposia on important health care issues
20
Journal of economic behavior & organization : JEBO
20
Research Paper
20
Allokation im marktwirtschaftlichen System
19
more ...
less ...
Source
All
ECONIS (ZBW)
111
Showing
1
-
50
of
111
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
1
HTA for pharmaceuticals in Europe : will the mountain deliver a mouse?
Garattini, Livio
;
Padula, Anna
- In:
The European journal of health economics : HEPAC ; …
21
(
2020
)
1
,
pp. 1-5
Persistent link: https://www.econbiz.de/10012221579
Saved in:
2
The impact of prescription drug co-payments for publicly insured families
Mohan, Gretta
;
Nolan, Anne
- In:
The European journal of health economics : HEPAC ; …
21
(
2020
)
2
,
pp. 261-274
Persistent link: https://www.econbiz.de/10012221954
Saved in:
3
Economic evaluation of meningococcal vaccines : considerations for the future
Christensen, Hannah
;
Al-Janabi, Hareth
;
Lévy, Pierre
; …
- In:
The European journal of health economics : HEPAC ; …
21
(
2020
)
2
,
pp. 297-309
Persistent link: https://www.econbiz.de/10012221975
Saved in:
4
Determination of the target population in early benefit assessments in Germany : challenges for non-small-cell lung cancer
TenThoren, C.
;
Balg, C.
;
Gibbert, J.
;
Mostardt, S.
; …
- In:
The European journal of health economics : HEPAC ; …
21
(
2020
)
6
,
pp. 881-893
Persistent link: https://www.econbiz.de/10012489317
Saved in:
5
A retrospective analysis of budget impact models submitted to the National Centre for Pharmacoeconomics in Ireland
Lamrock, Felicity
;
McCullagh, Laura
;
Tilson, Lesley
; …
- In:
The European journal of health economics : HEPAC ; …
21
(
2020
)
6
,
pp. 895-901
Persistent link: https://www.econbiz.de/10012489771
Saved in:
6
Predictors of negotiated prices for new drugs in Germany
Gandjour, Afschin
;
Schüßler, Sofia
;
Hammerschmidt, Thomas
- In:
The European journal of health economics : HEPAC ; …
21
(
2020
)
7
,
pp. 1049-1057
Persistent link: https://www.econbiz.de/10012489955
Saved in:
7
How French general practitioners respond to declining medical density : a study on prescription practices, with an insight into opioids use
Silhol, Julien
;
Ventelou, Bruno
;
Zaytseva, Anna
- In:
The European journal of health economics : HEPAC ; …
21
(
2020
)
9
,
pp. 1391-1398
Persistent link: https://www.econbiz.de/10012491084
Saved in:
8
International impact of external reference pricing : should national policy-makers care?
Fontrier, Anna-Maria
;
Gill, Jennifer
;
Kanavos, Panos
- In:
The European journal of health economics : HEPAC ; …
20
(
2019
)
8
,
pp. 1147-1164
Persistent link: https://www.econbiz.de/10012221319
Saved in:
9
Variations in external reference pricing implementation : does it matter for public policy?
Gill, Jennifer
;
Fontrier, Anna-Maria
;
Kyriopoulos, Dionysis
- In:
The European journal of health economics : HEPAC ; …
20
(
2019
)
9
,
pp. 1375-1397
Persistent link: https://www.econbiz.de/10012221376
Saved in:
10
Stratified medicine in schizophrenia : how accurate would a test of drug response need to be to achieve cost-effective improvements in quality of life?
Jin, Huajie
;
McCrone, Paul
;
MacCabe, James H.
- In:
The European journal of health economics : HEPAC ; …
20
(
2019
)
9
,
pp. 1425-1435
Persistent link: https://www.econbiz.de/10012221385
Saved in:
11
A systematic review of pharmacoeconomic evaluations of erlotinib in the first-line treatment of advanced non-small cell lung cancer
Nguyen Cuc Thi Thu
;
Petrelli, Fabio
;
Scuri, Stefania
; …
- In:
The European journal of health economics : HEPAC ; …
20
(
2019
)
5
,
pp. 763-777
Persistent link: https://www.econbiz.de/10012061274
Saved in:
12
Accuracy of budget impact estimations and impact on patient access : a hepatitis C case study
Geenen, Joost W.
;
Boersma, Cornelis
;
Klungel, Olaf H.
; …
- In:
The European journal of health economics : HEPAC ; …
20
(
2019
)
6
,
pp. 857-867
Persistent link: https://www.econbiz.de/10012061316
Saved in:
13
Costs of dose escalation among ulcerative colitis patients treated with adalimumab in Germany
Pöllinger, Bernadette
;
Schmidt, Wolfgang
;
Seiffert, Anna
; …
- In:
The European journal of health economics : HEPAC ; …
20
(
2019
)
2
,
pp. 195-203
Persistent link: https://www.econbiz.de/10012004819
Saved in:
14
Pricing of HPV vaccines in European tender-based settings
Qendri, Venetia
;
Bogaards, Johannes A.
;
Berkhof, Johannes
- In:
The European journal of health economics : HEPAC ; …
20
(
2019
)
2
,
pp. 271-280
Persistent link: https://www.econbiz.de/10012004859
Saved in:
15
Advanced therapy medicinal products and health technology assessment principles and practices for value-based and sustainable healthcare
Jönsson, Bengt
;
Hampson, Grace
;
Michaels, Jonathan
; …
- In:
The European journal of health economics : HEPAC ; …
20
(
2019
)
3
,
pp. 427-438
Persistent link: https://www.econbiz.de/10012005044
Saved in:
16
Methodological problems in the method used by IQWiG within early benefit assessment of new pharmaceuticals in Germany
Herpers, Matthias
;
Dintsios, Charalabos-Markos
- In:
The European journal of health economics : HEPAC ; …
20
(
2019
)
1
,
pp. 45-57
Persistent link: https://www.econbiz.de/10011998030
Saved in:
17
Economic evaluations of pharmacist-led medication review in outpatients with hypertension, type 2 diabetes mellitus, and dyslipidaemia : a systematic review
Ahumada-Canale, Antonio
;
Quirland, Camila
; …
- In:
The European journal of health economics : HEPAC ; …
20
(
2019
)
7
,
pp. 1103-1116
Persistent link: https://www.econbiz.de/10012220992
Saved in:
18
Competition in pharmaceuticals : more product- than price‑oriented?
Garattini, Livio
;
Padula, Anna
- In:
The European journal of health economics : HEPAC ; …
19
(
2018
)
1
,
pp. 1-4
Persistent link: https://www.econbiz.de/10011945818
Saved in:
19
Using health technology assessment to assess the value of new medicines : results of a systematic review and expert consultation across eight European countries
Angelis, Aris
;
Lange, Ansgar
;
Kanavos, Panos
- In:
The European journal of health economics : HEPAC ; …
19
(
2018
)
1
,
pp. 123-152
Persistent link: https://www.econbiz.de/10011946167
Saved in:
20
Patient preferences : a Trojan horse for evidence-based medicine?
Gandjour, Afschin
- In:
The European journal of health economics : HEPAC ; …
19
(
2018
)
1
,
pp. 167-172
Persistent link: https://www.econbiz.de/10011946179
Saved in:
21
The impact of physician-level drug budgets on prescribing behavior
Blankart, Katharina
;
Koch, Taika
;
Kostev, Karel
; …
- In:
The European journal of health economics : HEPAC ; …
19
(
2018
)
2
,
pp. 213-222
Persistent link: https://www.econbiz.de/10011946212
Saved in:
22
Determinants of health care costs in the senior elderly : age, comorbidity, impairment, or proximity to death?
Hazra, Nisha C.
;
Rudisill, Caroline
;
Gulliford, Martin
- In:
The European journal of health economics : HEPAC ; …
19
(
2018
)
6
,
pp. 831-842
Persistent link: https://www.econbiz.de/10011947266
Saved in:
23
Pharmaceutical pricing conundrum : time to get rid of it?
Garattini, Livio
;
Padula, Anna
- In:
The European journal of health economics : HEPAC ; …
19
(
2018
)
8
,
pp. 1035-1038
Persistent link: https://www.econbiz.de/10011948132
Saved in:
24
Comment on "Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany"
Gandjour, Afschin
- In:
The European journal of health economics : HEPAC ; …
19
(
2018
)
3
,
pp. 471-472
Persistent link: https://www.econbiz.de/10011952176
Saved in:
25
Authors' reply to Gandjour: "Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany"
Kuhlmann, Alexander
;
Schulenburg, Johann-Matthias von der
- In:
The European journal of health economics : HEPAC ; …
19
(
2018
)
3
,
pp. 473-481
Persistent link: https://www.econbiz.de/10011952179
Saved in:
26
Four years of early benefit assessment of new drugs in Germany : a qualitative study on methodological requirements for quality of life data
Blome, Christine
;
Augustin, Matthias
;
Metin, Hidayet
; …
- In:
The European journal of health economics : HEPAC ; …
18
(
2017
)
2
,
pp. 181-193
Persistent link: https://www.econbiz.de/10011867761
Saved in:
27
Why trash don't pass? : pharmaceutical licensing and safety performance of drugs
Banerjee, Tannista
;
Nayak, Arnab
- In:
The European journal of health economics : HEPAC ; …
18
(
2017
)
1
,
pp. 59-71
Persistent link: https://www.econbiz.de/10011867985
Saved in:
28
Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany
Kuhlmann, Alexander
;
Schulenburg, Johann-Matthias von der
- In:
The European journal of health economics : HEPAC ; …
18
(
2017
)
3
,
pp. 273-292
Persistent link: https://www.econbiz.de/10011868215
Saved in:
29
Out-of-pocket expenditures for pharmaceuticals : lessons from the Austrian household budget survey
Sanwald, Alice
;
Theurl, Engelbert
- In:
The European journal of health economics : HEPAC ; …
18
(
2017
)
4
,
pp. 435-447
Persistent link: https://www.econbiz.de/10011868658
Saved in:
30
The impact of race, income, drug abuse and dependence on health insurance coverage among US adults
Wang, Nianyang
;
Xie, Xin
- In:
The European journal of health economics : HEPAC ; …
18
(
2017
)
5
,
pp. 537-546
Persistent link: https://www.econbiz.de/10011868688
Saved in:
31
Why do health technology assessment coverage recommendations for the same drugs differ across settings? : applying a mixed methods framework to systematically compare orphan drug d...
Nicod, Elena
- In:
The European journal of health economics : HEPAC ; …
18
(
2017
)
6
,
pp. 715-730
Persistent link: https://www.econbiz.de/10011868947
Saved in:
32
Does drug price-regulation affect healthcare expenditures?
Ben-Aharon, Omer
;
Shavit, Oren
;
Magnezi, Racheli
- In:
The European journal of health economics : HEPAC ; …
18
(
2017
)
7
,
pp. 859-867
Persistent link: https://www.econbiz.de/10011869108
Saved in:
33
The social cost of drugs in France in 2010
Kopp, Pierre
;
Ogrodnik, Marysia
- In:
The European journal of health economics : HEPAC ; …
18
(
2017
)
7
,
pp. 883-892
Persistent link: https://www.econbiz.de/10011869112
Saved in:
34
Cost analysis and cost-benefit analysis of a medication review with follow-up service in aged polypharmacy patients
Malet-Larrea, Amaia
;
Goyenechea, Estíbaliz
; …
- In:
The European journal of health economics : HEPAC ; …
18
(
2017
)
9
,
pp. 1069-1078
Persistent link: https://www.econbiz.de/10011869543
Saved in:
35
Determinants of utilisation differences for cancer medicines in Belgium, Scotland and Sweden
Ferrario, Alessandra
- In:
The European journal of health economics : HEPAC ; …
18
(
2017
)
9
,
pp. 1095-1105
Persistent link: https://www.econbiz.de/10011869551
Saved in:
36
Entry time effects and follow-on drug competition
Andrade, Luiz Flavio
;
Sermet, Catherine
;
Pichetti, Sylvain
- In:
The European journal of health economics : HEPAC ; …
17
(
2016
)
1
,
pp. 45-60
Persistent link: https://www.econbiz.de/10011486246
Saved in:
37
Drug overprescription in nursing homes: an empirical evaluation of administrative data
Stroka, Magdalena A.
- In:
The European journal of health economics : HEPAC ; …
17
(
2016
)
3
,
pp. 257-267
Persistent link: https://www.econbiz.de/10011654600
Saved in:
38
Economic evaluation of a telephone- and face-to-face-delivered counseling intervention for smoking cessation in patients with coronary heart disease
Berndt, Nadine
;
Bolman, Catherine
;
Lechner, Lilian
; …
- In:
The European journal of health economics : HEPAC ; …
17
(
2016
)
3
,
pp. 269-285
Persistent link: https://www.econbiz.de/10011654605
Saved in:
39
The impact of non-financial and financial encouragements on participation in non school-based human papillomavirus vaccination : a retrospective
Lefevere, Eva
;
Hens, Niel
;
De Smet, Frank
;
Beutels, Philippe
- In:
The European journal of health economics : HEPAC ; …
17
(
2016
)
3
,
pp. 305-315
Persistent link: https://www.econbiz.de/10011654614
Saved in:
40
Differing types of medical prevention appeal to different individuals
Bouckaert, Nicolas
;
Schokkaert, Erik
- In:
The European journal of health economics : HEPAC ; …
17
(
2016
)
3
,
pp. 317-337
Persistent link: https://www.econbiz.de/10011654615
Saved in:
41
The importance of negative defensive medicine in the effects of malpractice reform
Montanera, Daniel
- In:
The European journal of health economics : HEPAC ; …
17
(
2016
)
3
,
pp. 355-369
Persistent link: https://www.econbiz.de/10011654621
Saved in:
42
Price offers of pharmaceutical procurement in China : evidence from Guangdong province
Yao, Ying
;
Tanaka, Makoto
- In:
The European journal of health economics : HEPAC ; …
17
(
2016
)
5
,
pp. 563-575
Persistent link: https://www.econbiz.de/10011654655
Saved in:
43
The impact of pharmaceutical innovation on premature cancer mortality in Switzerland, 1995-2012
Lichtenberg, Frank R.
- In:
The European journal of health economics : HEPAC ; …
17
(
2016
)
7
,
pp. 833-854
Persistent link: https://www.econbiz.de/10011654781
Saved in:
44
The simultaneous effects of pharmaceutical policies from payers' and patients' perspectives : Italy as a case study
Armeni, Patrizio
;
Jommi, Claudio
;
Otto, Monica
- In:
The European journal of health economics : HEPAC ; …
17
(
2016
)
8
,
pp. 963-977
Persistent link: https://www.econbiz.de/10011660118
Saved in:
45
The diffusion of generics after patent expiry in Germany
Blankart, Katharina
;
Stargardt, Tom
- In:
The European journal of health economics : HEPAC ; …
17
(
2016
)
8
,
pp. 1027-1040
Persistent link: https://www.econbiz.de/10011660160
Saved in:
46
Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany
Damm, Oliver
;
Eichner, Martin
;
Rose, Markus Andreas
; …
- In:
The European journal of health economics : HEPAC ; …
16
(
2015
)
5
,
pp. 471-488
Persistent link: https://www.econbiz.de/10011299236
Saved in:
47
Prevalence and treatment costs of type 2 diabetes in Germany and the effects of social and demographical differences
Sittig, D. T.
;
Friedel, Heiko
;
Wasem, Jürgen
- In:
The European journal of health economics : HEPAC ; …
16
(
2015
)
3
,
pp. 305-311
Persistent link: https://www.econbiz.de/10011299646
Saved in:
48
Compulsory licensing and access to drugs
Stavropoulou, Charitini
;
Valletti, Tommaso M.
- In:
The European journal of health economics : HEPAC ; …
16
(
2015
)
1
,
pp. 83-94
Persistent link: https://www.econbiz.de/10011300285
Saved in:
49
Competitive pricing within pharmaceutical classes : evidence on ‘‘follow-on’’ drugs in Germany 1993 - 2008
Mueller, Michael T.
;
Frenzel, Alexander
- In:
The European journal of health economics : HEPAC ; …
16
(
2015
)
1
,
pp. 73-82
Persistent link: https://www.econbiz.de/10011300287
Saved in:
50
Italian risk-sharing agreements on drugs : are they worthwhile?
Garattini, Livio
;
Curto, Alessandro
;
Van de Vooren, …
- In:
The European journal of health economics : HEPAC ; …
16
(
2015
)
1
,
pp. 1-3
Persistent link: https://www.econbiz.de/10011300361
Saved in:
1
2
3
Next
Last
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->